Objective: Unplanned hospital readmissions following surgical interventions are associated with adverse events and contribute to increasing health care costs. Despite numerous studies defining risk factors following lower extremity bypass surgery, evidence regarding readmission after endovascular interventions is limited. This study aimed to identify predictors of 30-day unplanned readmission following infrainguinal endovascular interventions.
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Questions Society for Vascular Surgery Phone: 800-258-7188; education@vascularsociety.org compared with those not readmitted (CLI, 3.4% vs 0.7% [P < .001]; claudication, 2.8% vs 0.1% [P < .01]). Approximately 50% of all unplanned readmissions were related to the index procedure. Among CLI patients, the most common indication for readmission related to the index procedure was wound or infection related (42%), whereas patients with claudication were mainly readmitted for recurrent symptoms of peripheral vascular disease (28%). In patients with CLI, predictors of unplanned readmission included diabetes (odds ratio, 1.3; 95% confidence interval, 1.01-1.6), congestive heart failure (1.6; 1.1-2.5), renal insufficiency (1.7; 1.3-2.2), preoperative dialysis (1.4; 1.02-1.9), tibial angioplasty/stenting (1.3; 1.04-1.6), in-hospital bleeding (1.9; 1.04-3.5), in-hospital unplanned return to the operating room (1.9; 1.1-3.5), and discharge other than to home (1.5; 1.1-2.0). Risk factors for those with claudication were dependent functional status (3.5; 1.4-8.7), smoking (1.6; 1.02-2.5), diabetes (1.5; 1.01-2.3), preoperative dialysis (3.6; 1.6-8.3), procedure time exceeding 120 minutes (1.8; 1.1-2.7), in-hospital bleeding (2.9; 1.2-7.4), and in-hospital unplanned return to the operating room (3.4; 1.2-9.4).
Conclusions: Unplanned readmission after endovascular treatment is relatively common, especially in patients with CLI, and is associated with substantially increased mortality. Awareness of these risk factors will help providers identify patients at high risk who may benefit from early surveillance, and prophylactic measures focused on decreasing postoperative complications may reduce the rate of readmission. ( Despite that endovascular procedures are now the most commonly used method for lower extremity revascularization, predictors of readmission after infrainguinal endovascular intervention are limited.
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Although Davenport et al 15 analyzed readmission data for both open and endovascular interventions, no predictors specific to endovascular procedures were identified. In addition, Vogel et al 16 evaluated outcomes in only a limited set of patients who underwent tibioperoneal angioplasty for CLI in the U.S. Medicare population. Therefore, the purpose of this study was to assess the incidence of 30-day unplanned readmission following infrainguinal endovascular intervention and to identify preoperative and in-hospital risk factors using a large national representative clinical registry.
METHODS
Data source. Patients were identified using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) targeted vascular module. NSQIP is a prospective clinical registry of surgical perioperative outcomes collected nationwide for the purpose of quality assessment and improvement. The registry consists of patient demographic, operative, and postoperative variables up to 30 days after surgery. The targeted vascular module contains additional detailed anatomic and intraoperative characteristics as well as procedure-related outcomes from 83 participating sites. According to NSQIP protocol, trained clinical nurses first identify surgical procedures by reviewing operative case logs, then collect data and categorize these procedures using Current Procedural Terminology (CPT) codes. Although not all cases are included, a systematic sampling system was developed by NSQIP to select cases and to prevent bias in selection. Data collection and quality control have been validated by annual audits and previous reports. [17] [18] [19] In 2011, NSQIP began collecting 30-day readmission events; however, the time to readmission, indication, and whether the readmission was related to the principal procedure became available only in 2012. Therefore, the data were evaluated for 2012-2014 only. Readmission data captured by NSQIP have been previously validated. 4 More details on this registry can be found at www. acsnsqip.org. The Beth Israel Deaconess Medical Center Institutional Review Board approved this study with informed consent waived because of the deidentified nature of NSQIP.
Patients. Patients undergoing an infrainguinal endovascular intervention as a principal procedure were included (CPT code: 37224-37233). Extra procedural detail regarding treatment approach was not captured by NSQIP, which precluded us from determining whether the endovascular intervention was a percutaneous or an open procedure. Those not at risk for readmission because of death during the index admission (n ¼ 75; 1.7%) or patients with a hospital stay longer than 30 days (n ¼ 51; 1.1%) were excluded from the analysis. We stratified patients by symptom status, either intermittent claudication or CLI. Patients with and without unplanned readmission were compared on baseline characteristics, intraoperative details, and postoperative outcomes.
Preoperative and intraoperative characteristics. Baseline characteristics consisted of demographics, comorbidities, and preprocedural medication. Age was considered a categorical and a continuous variable; however, all patients 90 years of age or older are recorded as 90þ by NSQIP to prevent individual patient identification. Smoking included current tobacco use or within the last year before intervention. Preoperative documentation of an open wound or infection was captured, although the location could not be determined with NSQIP data. Dependent functional status was defined as partial or total assistance for activities of daily living captured within 30 days before the procedure. Intraoperative details captured were type of procedure, American Society of Anesthesiologists (ASA) class, procedure time, and whether the procedure was elective. Concurrent procedures were identified with corresponding CPT codes (Supplementary Table I , online only); however, we were unable to distinguish whether the concurrent procedure was ipsilateral or contralateral on the basis of these billing codes.
Readmissions. The primary outcome was any unplanned readmission within 30 days of the principal endovascular procedure to any hospital, which is referred to as unplanned readmission in this study. Unplanned readmission was captured by an NSQIP variable and excluded elective or planned readmissions. In addition, unplanned readmissions were further categorized within NSQIP as related or unrelated to the principal procedure, and this distinction cannot be made for planned readmissions. Related unplanned readmission indications were determined with a specific list of NSQIP complications or International Classification of Diseases, Ninth Revision (ICD-9) codes (Supplementary Table II , online only). Limb-related readmissions were defined as all readmissions related to the ipsilateral index limb or endovascular procedure. An infection or wound complication refers to a composite variable using ICD-9 codes, which subsequently does not allow us to differentiate between pre-existing wounds and postoperative complications. We defined recurrent symptoms of peripheral vascular disease as worsening of peripheral vascular symptoms likely related to atherosclerotic disease, stenosis, occlusion, or failure of treatment.
Outcomes. Other postoperative outcomes included mortality after index admission and 30-day adverse events. Both 30-day and in-hospital (during the index admission) complications were captured, provided that a time-to-event variable was documented. Major adverse limb event refers to a composite variable containing major amputation (above or below knee) or major reintervention (new or revision bypass graft; thrombectomy or thrombolysis; or major surgical revision, such as jump or interposition graft). Surgical site infection or complication included any surgical site infection or wound dehiscence. Bleeding was defined as any transfusion or secondary procedure with the indication of bleeding. A respiratory complication was considered present when one of the following was documented: pneumonia, unplanned reintubation, or ventilator requirement >48 hours. Any complication included myocardial infarction, stroke, bleeding, surgical site infection or complication, renal deterioration (creatinine concentration >2 mg/dL or need for dialysis), respiratory complications, sepsis, septic shock, untreated loss of patency, and unplanned return to the operating room. Discharge other than to home was defined as any discharge to a skilled or unskilled nursing facility in those patients who were originally admitted from home. These variable definitions were determined by NSQIP before data collection and thus were not modifiable.
Statistical analysis. Differences between patients with and without unplanned readmission were determined using the Pearson c 2 and Fisher exact test for categorical variables; continuous variables were analyzed by Student t-test and Mann-Whitney U test, where appropriate. Multivariable logistic regression was performed to establish independent associations with 30-day unplanned readmission. For adjusted analysis, models were constructed using purposeful selection of covariates, incorporating backward elimination after univariate testing (P value # .1). 20 Separate regression models were constructed for patients with CLI and claudication, and the cutoff value for procedure time and length of stay was the 75th percentile. Statistical significance was defined as 
RESULTS
A total of 4449 patients were included in the study, of whom 63% (n ¼ 2802) had CLI (66% of these had tissue loss) and 37% (n ¼ 1647) had claudication. Among patients with CLI, the 30-day unplanned readmission rate was 16% (n ¼ 447), and of those patients, 5.1% (n ¼ 23) were readmitted more than once. The unplanned readmission rate in patients with claudication was 6.5% (n ¼ 107), and of those patients, 2.8% (n ¼ 3) had more than one readmission. To put this into perspective, planned readmissions within 30 days occurred in 2.2% (n ¼ 62) for CLI patients and in 1.5% (n ¼ 25) for those with claudication.
Baseline characteristics. Table I summarizes patients' baseline characteristics. Compared with CLI patients without an unplanned readmission, those with an unplanned readmission were less likely to be white (53% vs 60%; P ¼ .04), were more often functionally dependent (19% vs 15%; P ¼ .02), and more frequently had tissue loss (71% vs 65%; P ¼ .02). Patients who were readmitted more often had diabetes (70% vs 61%; P < .001), congestive heart failure (7.4% vs 3.9%; P ¼ .001), renal insufficiency (49% vs 31%; P < .001), dialysis (24% vs 12%; P < .001), and a preoperative open wound or infection (60% vs 51%; P < .001). Finally, among patients with CLI, preoperative use of statin (73% vs 67%; P ¼ .02) and betablocker medications (71% vs 65%; P ¼ .01) was more frequent in those readmitted.
In claudication patients, unplanned readmission was associated with dependent functional status (6.6% vs 1.6%; P < .001), diabetes (51% vs 40%; P ¼ .02), dialysis (8.4% vs 2.3%; P < .001), preoperative open wound or infection (16% vs 3.8%; P < .001), and preoperative use of beta-blocker medications (66% vs 57%; P ¼ .047).
Procedure details. Compared with CLI patients without an unplanned readmission, those who were readmitted had a significantly longer procedure time (102 vs 92 minutes; P < .01; Table II ) and were less likely to undergo an elective procedure (48% vs 54%; P ¼ .03). Similarly, ASA class $4 (29% vs 21%; P < .001) and tibial angioplasty or stenting (34% vs 26%; P ¼ .001) were more common among readmitted CLI patients. In most cases, vascular surgeons performed the procedure as opposed to other specialties (92% vs 8%). Among patients with claudication, those with unplanned readmissions more often underwent tibial angioplasty or stenting compared with those without an unplanned readmission (14% vs 8.4%; P ¼ .046). In addition, readmitted patients had a longer procedure time (102 vs 81 minutes; P < .001) and more frequently had an ASA class $4 (24% vs 8.9%; P < .001). Vascular surgeons performed more endovascular procedures than other specialties (85% vs 15%). Regarding concurrent procedures, readmitted patients with claudication more often underwent an additional thromboendarterectomy compared with those not readmitted (13% vs 5.4%; P ¼ .001).
Postoperative outcomes. Postoperative outcomes are detailed in Table III . Mortality after index admission was higher in readmitted patients for both CLI (3.4% vs 0.7%; P < .001) and claudication (2.8% vs 0.1%; P < .01). Time to readmission occurred at a median of 12 days after discharge in patients with CLI (interquartile range, 6-19) and 13 days in those with claudication (interquartile range, 7-18). The 30-day rate of any complication in CLI patients with an unplanned readmission was higher than in those not readmitted (61% vs 15%; P < .001). Readmitted patients with claudication also suffered more complications (66% vs 4.9%; P < .001). In patients with an unplanned readmission, the following 30-day adverse Indications for readmission. Of all unplanned readmissions, approximately half were considered related to the index endovascular procedure in patients with CLI (49%) and claudication (53%). Indications for readmission varied by symptom status and are listed in Table IV . In CLI patients, readmissions were limb related in 72%, which included 42% infection or wound complications, and 14% were due to recurrent symptoms of peripheral vascular disease. Readmission indications in patients with claudication were also primarily limb related (68%), with 8.8% readmitted because of infection or wound complications and 28% of patients readmitted for recurrent symptoms of peripheral vascular disease.
Predictors of unplanned readmission. Multivariable predictors of 30-day unplanned readmission are listed in Table V . Preoperative independent risk factors of any unplanned readmission in patients with CLI were diabetes (odds ratio [OR], 1.3; 95% confidence interval
[CI], 1.01-1.6), congestive heart failure (OR, 1.6; 95% CI, 1.1-2.5), renal insufficiency (OR, 1.7; 95% CI, 1.3-2.2), and preoperative dialysis (OR, 1.4; 95% CI, 1.02-1.9). Intraoperatively, tibial angioplasty or stenting (OR, 1.3; 95% CI, 1.04-1.6) was also associated with an increased risk of unplanned readmission. Additional predischarge risk factors were in-hospital bleeding (OR, 1.9; 95% CI, 1.04-3.5) and unplanned return to the operating room (OR, 1.9; 95% CI, 1.1-3.5). Finally, discharge other than to home was associated with unplanned readmission in CLI patients (OR, 1.5; 95% CI, 1.1-2.0). Among patients with claudication, predictors of any unplanned readmission included dependent functional status (OR, 3.5; 95% CI, 1.4-8.7), smoking (OR, 1.6; 95% CI, 1.02-2.5), diabetes (OR, 1.5; 95% CI, 1.01-2.3), preoperative dialysis (OR, 3.6; 95% CI, 1.6-8.3), and procedure time exceeding 120 minutes (OR, 1.8; 95% CI, 1.1-2.7). Similar to patients with CLI, unplanned readmission in those with claudication was also independently associated with predischarge complications, such as in-hospital bleeding (OR, 2.9; 95% CI, 1.2-7.4) and in-hospital unplanned return to the operating room (OR, 3.4; 95% CI, 1.2-9.4).
DISCUSSION
This study demonstrates that 30-day unplanned readmission after infrainguinal endovascular intervention is relatively common for CLI (1 in 6 patients) and claudication (1 in 15 patients). Also, mortality and morbidity after index admission were significantly worse in those readmitted. Adjusted analysis demonstrated that diabetes, congestive heart failure, renal insufficiency, preoperative dialysis, and tibial angioplasty or stenting were independent predictors of unplanned readmission in CLI patients. Other risk factors included postoperative adverse events, such as in-hospital bleeding, in-hospital unplanned return to the operating room, and discharge other than to home. Among patients with claudication, risk factors for unplanned readmission were dependent functional status, smoking, diabetes, preoperative dialysis, and procedure time exceeding 120 minutes as well as in-hospital factors, such as bleeding and unplanned return to the operating room.
Several other studies have evaluated readmission rates of endovascular procedures, although few of these stratified by symptom status and whether a readmission was planned or unplanned. An analysis between 2008 and 2010 of the Health Facts database, which records longitudinal patient data from >480 contributing institutions throughout the United States, found a readmission rate of 19% in 251 patients with CLI and 11% in 221 claudication patients undergoing endovascular intervention, whereas a single-institution study of 137 endovascular interventions showed that 12% of CLI patients and 2.2% of claudication patients were readmitted. 21, 22 Our rates of 16% in patients with CLI and 6.5% in those with claudication fall well within these reported ranges. The variation may be partly attributable to differences in follow-up time, namely, 30 days from discharge (both previous studies) rather than from the procedure, which was assessed in the current study. Our rates may be higher than those reported from Jackson et al 22 as NSQIP captures readmissions even at different institutions, therefore providing a more complete representation of all readmissions. Whereas the 30-day period is limited, we believe that it still represents a critical period, especially in light of the short time between an endovascular procedure and typical discharge. When comparing our results to studies conducted among patients undergoing infrainguinal bypass surgery, we found similar predictors of readmission. [7] [8] [9] [10] [11] [12] Only one other study, by Vogel et al, 16 identified predictors of readmission following tibioperoneal angioplasty using the U.S. Medicare database and showed that gangrene, chronic heart failure, chronic obstructive pulmonary disease, and renal failure were independent risk factors of 30-day unplanned readmission in CLI patients. The association between renal failure and higher risk of readmission has been demonstrated previously, 2, 9, 12, 15, 21 and the present study further supports that end-stage renal disease correlates with worse outcomes, in particular a 1.4-fold and 3.6-fold increased risk of readmission in patients with CLI and claudication, respectively. Whereas the study by Vogel et al included >13,000 patients, Medicare uses administrative discharge data for billing purposes, which limits the ability to appropriately capture comorbidities, functional status, and operative details. In contrast, NSQIP is not an administrative database but rather a clinical registry that uses clinical reviewers to evaluate operative and progress notes and also gathers complete 30-day follow-up data through outpatient chart review and telephone follow-up. There are important clinical implications to this study. Many preoperative risk factors are not directly modifiable; however, this study merely reinforces the importance of addressing chronic issues and optimizing coexisting conditions. Furthermore, attention should be focused on procedure-related and in-hospital complications as these are more modifiable and may provide opportunities to further lower readmission rates. Previous studies reported similar postoperative complications, such as bleeding and unplanned return to the operating room, as risk factors, 12, 15 which may be attributed to anatomy-or procedure-specific difficulties. However, given their strong association with readmission, care should be taken to minimize blood loss, and in the occurrence of complications, close monitoring and evaluation before discharge may be appropriate, such as duplex ultrasound evaluation for pseudoaneurysm in the event of a groin hematoma. Consistent with findings of others, 8, 15, [23] [24] [25] our data showed an association between readmission and discharge destination. This is likely related to more advanced comorbidities and worsening functional status, which may not be modifiable. However, advancements in communication between physicians at the hospital and health care professionals at skilled nursing facilities both at time of discharge and after may help to improve transition of care and patient outcomes. 26 Caution is warranted in the use of invasive interventions in patients with claudication, especially tibial revascularization and procedures in those with a poor functional health status, given that these were associated with readmission. In addition, risk reduction guidelines or programs, such as smoking cessation, are associated with reduced postoperative complications and limb events 27, 28 and are likely to improve outcomes of patients with claudication. Some have suggested withholding surgical treatment until the patient has stopped smoking, which is adopted by the Society for Vascular Surgery Lower Extremity Guidelines Committee that recommends multidisciplinary smoking cessation efforts in those with claudication, repeatedly before interventions.
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In patients with CLI, the majority of hospital readmissions identified in this study were related to infection and wound complication, with 42% of all readmissions. Other studies have shown similar readmission rates due to infectious complications after infrainguinal revascularization, ranging from 38% to 55%. 11, 12, 15, 25 that readmissions after surgical procedures appeared evenly dispersed over time with no particular peak following discharge. In our analysis, patients with CLI and claudication were readmitted at a median of 12 and 13 days, respectively. As addressed previously, early medical follow-up may be strategically timed. 2 Capturing adverse events during early surveillance may allow treatment in the outpatient setting, for example, by nurseconducted telephone calls 1 week after discharge or improved utilization of skilled nursing facilities. Moreover, identifying high-risk patients can help to prioritize patients who should be seen in the clinic sooner after discharge. Whereas we found higher readmission rates in those patients with a longer hospital stay, no association was demonstrated in the adjusted analysis. Some may argue that keeping patients admitted for a few additional days may avert potential readmissions, although whether this reduces postdischarge complications remains to be seen. Given that NSQIP follow-up ends at 30 days after intervention, a longer length of stay shortens postdischarge follow-up and necessarily reduces the patient's time at risk of readmission. Therefore, this study was unable to provide an accurate estimate in regard to the incidence of readmission in considering hospital stay duration, albeit short after endovascular intervention.
This study has several limitations that should be addressed. First, as NSQIP collects data through a clinical registry, it is subjected to data misclassification and limited by variable definitions. Second, confounding by indication may occur because patients undergoing angioplasty were potentially unsuitable for open bypass surgery, despite adjustment for all reported baseline characteristics in the multivariable analysis. In addition, this study was unable to assess the lesion severity, the extent of peripheral arterial disease, and the location of the puncture site or incision (eg, groin, arm, lower leg), which will likely have an impact on outcomes. Nonetheless, we believe that the targeted vascular module of NSQIP is a nationally representative and robust clinical registry that allows reliable risk assessment in the 30-day postoperative period. As this study can assess only 30-day outcomes, further research is needed to identify the full implications of unplanned readmissions on a patient and national level. The Society for Vascular Surgery Vascular Quality Initiative registry provides more detailed variables, including closure device and ultrasound use, that may further explain associations found in this study.
CONCLUSIONS
This study demonstrates that unplanned readmission following endovascular intervention is relatively common and associated with increased morbidity and mortality. In both patients with CLI and patients with claudication, risk factors for unplanned readmission include patient characteristics and procedure-related factors as well as occurrence of in-hospital complications, such as bleeding and unplanned return to the operating room. Many readmissions may not be avoidable, particularly in the CLI population, because of the extent of the comorbidities and socioeconomic status. However, this should not dissuade us from making efforts to optimize coexisting conditions, to involve case managers to improve postdischarge care, and to consider nurseconducted phone calls to assess for potential complications that may be managed in an outpatient setting if identified early. 
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